6 All thymomas originate from epithelial thymic cells 4% of them consist of a pure population of epithelial cells Most have mixed populations of lymphoid cells to a varying extent
7 20% of all mediastinal neoplasms 50% of all primary tumors in the anterior compartment 90% of thymic tumors are thymomas
8 Slow-growing tumors Exhibit malignant potential: Local invasion Systemic metastasis without overt cytological features of malignancy More common between ages 40 to 60
9 ~50% - asymptomatic, discovered incidentally on CXR or at autopsy ~30% local symptoms related with pressure or local invasion: SVC sdr., cough, chest pain, dysphonia, dysphagia ~20%- 70% associated with an autoimmiune disease: Myasthenia gravis Pure red cell aplasia Polymyosistis hypogammaglobulnemia
10 Chest CT scan is the imaging procedure of choice Thymic enlargement should be determined because most enlarged thymus glands on CT scan represent a thymoma. CT scan with intravenous contrast dye is preferred to show the relationship between the thymoma and surrounding vascular structures, to define the degree of its vascularity, and to guide the surgeon in removal of a large tumor, possibly involving other mediastinal structures
14 Magnetic resonance imaging (MRI). An MRI uses magnetic fields, not x-rays, to produce detailed images of the body. Positron emission tomography (PET) scan. In a PET scan, radioactive sugar molecules are injected into the body. Cancer cells absorb sugar more quickly than normal cells, so they light up on the PET scan. PET scans are often used to complement information gathered from CT scan, MRI, and physical examination. CT scanning reveals evidence of an anterior mediastinal mass, the PET scan shows a hypermetabolic mass consistent with this location, thereby raising suspicion of malignancy. PET scanning should be added to the armamentarium as an available diagnostic modality to aid in staging and excluding extramediastinal involvement
15 Biopsy: If a patient presents with atypical features or is found to have an invasive tumor and is under consideration for induction therapy, obtaining preoperative biopsy is indicated. The limited anterior mediastinotomy (Chamberlain approach) is the standard approach that typically is performed over the projection of the tumor. A thoracoscopic approach for biopsy also can be used
16 No clear histologic distinction between benign and malignant thymomas exists. The propensity of a thymoma to be malignant is determined by the invasiveness of the thymoma.
18 The preferred approach is a median sternotomy providing adequate exposure of the mediastinal structures and allowing complete removal of the thymus, If the tumor is small and appears readily accessible, perform a total thymectomy with contiguous removal of mediastinal fat. If the tumor is invasive, perform a total thymectomy in addition to en bloc removal of involved pericardium, pleura, lung, phrenic nerve, innominate vein, or superior vena cava. Resect one phrenic nerve; however, if both phrenics are involved, do not resect either nerve, and debulk the area. Clip areas of close margins or residual disease to assist the radiation oncologist in treatment planning
19 Their morphologic heterogeneity has caused much confusion regarding their classification. Several classifications have been proposed to correlate histology and clinical course. Previous studies have shown that the mediastinal invasion as reflected by the staging system of Masaoka negatively affects survival
20 Tumor extent but also grading the tumor could be required to predict prognosis and recurrence pattern which might help to define more precisely the role of adjuvant and neoadjuvant treatments. Therefore, not only staging, the several histologic classifications have been assessed, but they did not help to predict the evolution of thymic tumors after resection
21 WHO Histologic Description Free Survival at 10 years, % A Medullary thymoma 100 AB Mixed thymoma 100 B1 Predominantly cortical thymoma 83 B2 Cortical thymoma 83 B3 Well-differentiated thymic carcinoma 35 C Thymic carcinoma 28 Series of 100 thymomas resected in Japan between 1973 and 2001 using the WHO classification.
22 The prognosis of a person with a thymoma is based on the tumor's gross characteristics at operation, not the histological appearance. Benign tumors are noninvasive and encapsulated. Conversely, malignant tumors are defined by local invasion into the thymic capsule or surrounding tissue. The Masaoka staging system of thymomas is the most commonly accepted system. Preponderance of evidence indicates that all thymomas, except completely encapsulated stage 1 tumors, benefit from adjuvant radiation therapy
23 Relapse after primary therapy for a thymoma may occur after years. Therefore, long-term follow-up probably should continue to be performed throughout the patient's life.
24 Multivariate analysis showed age, gender, myasthenia gravis, and postoperative adjuvant therapy not to be significant predictors of survival after complete resection, whereas the Muller-Hermelink and Masaoka classifications were independent significant predictors for overall (p < 0.05)
27 Uncommon and lethal cancer. Currently no standard treatment. Asbestos exposure is major risk factors.
28 Asbestos belongs to the family of silicate fiber. Include two mineralogical groups: Amphibole and Serpentine.
29 Narrow and straight fibers. Migrate through the lymphatics of pulmonary parenchyma and accumulate in interstitial space and subpleural region. Crocidolite asbestos(blue asbestos)-- The most associate with malignant mesothelioma.
30 Large, curly shaped fiber. do Not travel beyond the major airways. Chrysotile(white asbestos, the only member of Serpentin) -- More associate with lung cancer.
32 Abnormal ECG Sinus tachycardia (42%). Echocardiographic findings. No specific tumor marker. Rise serum hyaluronan. CA-125 (20%).
33 Chest-x ray Variable and related to stage of tumor. Large pleural effusion, pleural thickening, pleural-based mass. Encasement of lung and obliteration of pleural space. Involve pericardium and pericardial effusion. Chest wall invasion, invasion through diaphragm. CT Most accurate noninvasive way to stage. PET scan.
37 Thoracentesis, cytology(positive rate 30-50%). Percutaneous pleural biopsy. Thoracoscopy. Open pleural biopsy. AVOID Exploratory thoracotomy. Bronchoscopy. Meidastinoscopy. Bone scans.
38 An accurate staging system is needed to guide the choice of therapy for patients with mesothelioma and ultimately to assess the results of treatment with different modalities Staging systems The most widely used staging system is the tumor (T), node (N), metastasis (M) staging system that has been adopted by both the International Union Against Cancer (UICC) and the American Joint Committee on Cancer
39 Clinical staging of malignant mesothelioma is performed radiographically in patients with potentially resectable malignant mesothelioma. Although radiographic staging evaluation is warranted, accurate staging is only possible at the time of operation
40 Patient with malignant mesothelioma face a dual problem Control of the locoregional tumor throughout the course of their disease, prevention of distant metastases as late manifestation of their cancer. Choice of treatment Location and extent of he tumor, the general medical condition of patient. Surgery, radiation, chemotherapy, immunotherapy, supportive care.
41 Still the mainstay of treatment. Three operation (1). Extrapleural pneumonectomy. (pleuropneumonectomy) (2). Pleurectomy-decortication. (3). Palliative limited pleurectomy.
42 En bloc resection of pleura, lung, ipsilateral hemidiaphragm, pericardium, Value Controversial. Operative mortality 6-30%. Preoperative CT, lung function, ventilationperfusion scan, cardiac function evaluate.
43 Remove all gross pleural disease, without removing underlying lung. Also remove hemidiaphragm and pericardium.
44 Resection parietal pleura to control pleural effusion. Thoracoscopy and talc poudrage High effective in controlling effusion.
45 The choice of a specific procedure EPP versus P/D is a function of the extent of disease within the thorax and the surgeon s judgement on the ability to achieve a MCR while preserving lung parenchyma. There are no randomized trials that compare EPP versus P/D.
47 Patients with malignant pleural mesothelioma typically present with pulmonary symptoms. Chest imaging typically shows unilateral pleural thickening and pleural effusion. Paraneoplastic syndromes can be associated with pleural mesothelioma, but rarely are the initial manifestation of disease. The diagnosis of malignant mesothelioma requires a tissue sample. The differential diagnosis of malignant pleural mesothelioma includes inflammatory reactions, which can mimic pleural mesothelioma, as well as metastases from other malignancies. Thoracentesis and closed pleural biopsy are the initial procedures in most cases. If this is not diagnostic, surgical intervention is required to obtain an adequate tissue sample.
48 Clinical staging primarily relies upon imaging studies to assess the extent of disease and determine whether or not the patient is a candidate for surgical resection. However, clinical staging often underestimates the extent of disease, and intraoperative staging provides a more reliable assessment of whether or not the patient is a candidate for surgical resection.
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
Malignant Mesothelioma Current Approaches to a Difficult Problem Raja M Flores, MD Thoracic Surgery Memorial Sloan-Kettering Cancer Center Malignant Pleural Mesothelioma Clinical Presentation Insidious
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
Thymus Cancer Introduction Thymus cancer is a rare cancer. It starts in the small organ that lies in the upper chest under the breastbone. The thymus makes white blood cells that protect the body against
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis . Most are
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer begins in our cells. Cells are the building blocks of our tissues. Tissues make up the organs of the body.
General Information About Non-Small Cell Lung Cancer Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
MESOTHELIOMA Not Just a Late Night Commercial Graciela Hoal, RN, MSN, ACNP-BC Saturday Session Thoracic Surgery Nurse Practitioner Greater Los Angeles Veteran Affairs Objectives Course Objectives: Discuss
Lung Cancer What is cancer? First, some background on the way the body is built. Organs, like the heart, liver, and lung, are made up of tissues, such as blood vessels and muscle. Tissues, in turn, are
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); email@example.com Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Presented By Ahmed Farouk Abd El-Hafez, MD Lecturer of Cardiothoracic Surgery Assiut University Asbestos exposure : amphibole fibers especially crocidolite asbestos Nonasbestos Causes : Silicate fibers
What is Mesothelioma? Mesothelioma is a rare type of cancer that develops in the mesothelial cells found in one s body. These cells form membranous linings that surround and protect the body s organs and
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
Therapy of pleural effusions Modern techniques Dr. Melanie Toffel Sugery of the chest Pleural effusion Ethiology In the normal pleural space there is a steady state in which there is a roughly equal rate
PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1 Jonathan C. Daniel 2 Kenneth S. Knox 1 Kathleen Williams 1 Departments of Medicine 1 and Surgery 2, University
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
Treatment Guide Lung Cancer Management The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute and Miller Family Heart & Vascular
Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.
There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers
For media outside the US, UK and Canada only P L E U R A L M E S O T H E L I O M A 1. Overview 2. What is pleural mesothelioma? 3. How common is pleural mesothelioma? 4. What are the risk factors for pleural
Patient Guide ASCOInformation for People Living with Cancer ADVANCED LUNG CANCER TREATMENT Recommendations of the American Society of Clinical Oncology Welcome The American Society of Clinical Oncology
Malignant Pleural Mesothelioma NCCN Guidelines for Patients Presented with support from the national law firm of Baron & Budd Also available at NCCN.com About this booklet Its purpose Learning that you
Lung Cancer B. Dingle MD, FRCPC, Brian Yaremko MD,FRCPC, R. Ash, MD, FRCPC, P. Truong, MD, FRCPC EPIDEMIOLOGY The estimated incidence of lung cancer in Canada for 2007 is 23,300 with 12,400 occurring in
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
Neoplasms of the LUNG and PLEURA 2015-2016 FCDS Educational Webcast Series Steven Peace, BS, CTR September 19, 2015 2015 Focus o Anatomy o SSS 2000 o MPH Rules o AJCC TNM 1 Case 1 Case Vignette HISTORY:
Information Booklet for Patients Understanding Your Surgical Options for Lung Cancer Understanding Lung Cancer If you have just been diagnosed with lung cancer, this booklet will serve as an informational
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
CHAPTER 4: LUNG CANCER DIAGNOSIS AND STAGING INTRODUCTION The lungs are vital organs. Working with the heart and circulatory system, they provide lifesustaining oxygen and rid the body of carbon dioxide.
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto Asbestos related diseases Mesothelioma Lung
Lung Cancer and Mesothelioma Robert Kratzke, M.D. John C. Skoglund Professor of Lung Cancer Research Section of Heme/Onc/Transplant Department of Medicine University of Minnesota Medical School Malignant
Malignant Mesothelioma What is malignant mesothelioma? Malignant mesothelioma is a cancer that starts in cells in the linings of certain parts of the body, especially in the linings of the chest or abdomen.
Imaging Diagnosis and Staging of Lung Cancer By Mamdouh Mahfouz MD Radio diagnosis Cairo University firstname.lastname@example.org www.ssregypt.com Lung Cancer The most common cause of deaths worldwide Cigarette
July 2014 Tina Mosaferi, Harvard Medical School Year III 1. Our Patient-Introduction 2. Asbestos Basics 3. Pulmonary Findings Manifestations demonstrated by companion patients 4. Our patient-conclusion
Work-up of Suspected Lung Cancer Gordon Buduhan MD MSc FRCSC Section of Thoracic Surgery Lung Cancer Educational Program November 2013 Presenter disclosure No conflicts to disclose Scope of the problem
Avastin: Glossary of key terms Adenocarcinoma Adenoma Adjuvant therapy Angiogenesis Anti-angiogenics Antibody Antigen Avastin (bevacizumab) Benign A form of carcinoma that originates in glandular tissue.
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy
Basic Data 鍾 XX, female Age:59 y/o Chief complain for evaluation of the left pleural mass Clinical course This 59 years old lady Hypertension for 3 years, under herbal control. An episode of high BP up
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
LUNG CANCER: A CLINICIAN S PERSPECTIVE Michelle Wong Chris Hani Baragwanath Hospital IAEA PET/CT Workshop: Improving Patient Care 2 November 2010 EPIDEMIOLOGY OF LUNG CANCER Most common cause of cancer
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
Non-Small Cell Lung Cancer About Your Lungs and Lung Cancer How do your lungs work? To understand lung cancer it is helpful to understand your lungs. Your lungs put oxygen into the blood, which the heart
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits
Liver Cancer What is the liver? The liver is the largest internal organ in the body and is important in digesting food. The liver performs many other functions, including collecting and filtering blood
A PATIENT S GUIDE TO ABLATION THERAPY THE DIVISION OF VASCULAR/INTERVENTIONAL RADIOLOGY THE ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL Treatment options for patients with cancer continue to expand, providing
Main Page Risk Factors Reducing Your Risk Screening Symptoms Diagnosis Treatment Overview Chemotherapy Radiation Therapy Surgical Procedures Lifestyle Changes Managing Side Effects Talking to Your Doctor
Information for Patients with an Abnormal Lung X-Ray Some of the materials in this resource were adapted, with permission, from: Understanding Lung Cancer, Juravinski Cancer Centre, Hamilton Health Sciences,
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
Understanding Pancreatic Cancer Understanding Pancreatic Cancer The Pancreas The pancreas is an organ that is about 6 inches long. It s located deep in your belly between your stomach and backbone. Your
Lung Cancer Radiation Therapy in the Treatment of Lung Cancer JMAJ 46(12): 537 541, 2003 Kazushige HAYAKAWA Professor and Chairman, Department of Radiology, Kitasato University School of Medicine Abstract:
Lung Cancer Understanding your diagnosis Lung Cancer Understanding your diagnosis When you first hear that you have cancer you may feel alone and afraid. You may be overwhelmed by the large amount of information
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
Mesothelioma Understanding your diagnosis Mesothelioma Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount of
Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic
central east regional cancer program in partnership with cancer care ontario THORACIC DIAGNOSTIC ASSESMENT PROGRAM (DAP) PATIENT INFORMATION FOR: Thoracic dap booklet March2012.indd 1 SCHEDULED TESTS YOUR
Lung Carcinoid Tumor What are lung carcinoid tumors? Lung carcinoid tumors (also known as lung carcinoids) are a type of lung cancer, which is a cancer that starts in the lungs. Cancer starts when cells
What is cancer? Thymus Cancer The body is made up of trillions of living cells. Normal body cells grow, divide into new cells, and die in an orderly way. During the early years of a person s life, normal
Management of spinal cord compression (SUMMARY) Main points a) On diagnosis, all patients should receive dexamethasone 10mg IV one dose, then 4mg every 6h. then switched to oral dose and tapered as tolerated
The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name
Invasive Staging for NSCLC Allan Pickens, MD Assistant Professor of Surgery Section of Thoracic Surgery Emory University Presentation 1600 1400 1200 1000 800 600 400 200 0 IA IB IIA IIB IIIA IIIB IV Stage